Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAttovia Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Attovia Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Aug 6, 2026GOLDMAN SACHS GROUP INCFormer 10% Owner4,445,275Series C Preferred Stock—Conversion
Aug 6, 2026GOLDMAN SACHS GROUP INCFormer 10% Owner18,181,830Series B Preferred Stock—Conversion
Aug 6, 2026GOLDMAN SACHS GROUP INCFormer 10% Owner500,000Common Stock—Buy
Aug 6, 2026GOLDMAN SACHS GROUP INCFormer 10% Owner2,435,632Common Stock—Conversion
Aug 6, 2026WALSH COLINDirector500,000Common Stock—Buy
Aug 6, 2026WALSH COLINDirector2,435,632Common Stock—Conversion
Aug 6, 2026venBio Global Strategic Fund IV, L.P.10% Owner382,352Common Stock—Buy
Aug 6, 2026venBio Global Strategic Fund IV, L.P.10% Owner3,799,015Common Stock—Conversion
Aug 6, 2026Deep Track Biotechnology Master Fund, Ltd.10% Owner1,957,138Common Stock—Conversion
Aug 6, 2026Redmile Group, LLC10% Owner600,000Common Stock—Buy
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
$20.83Close · Sep 22, 2026